Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Concentrix Corp’s stock clocked out at $40.31, down -1.59% from its previous closing price of $40.96. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 1.04 million shares were traded. CNXC stock price reached its highest trading level at $41.0 during the session, while it also had its lowest trading level at $39.74.
Ratios:
To gain a deeper understanding of CNXC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.87. For the most recent quarter (mrq), Quick Ratio is recorded 1.56 and its Current Ratio is at 1.56. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 30 ’25 when Caldwell Christopher A bought 2,000 shares for $42.03 per share. The transaction valued at 84,056 led to the insider holds 286,661 shares of the business.
Twomey Cormac J sold 500 shares of CNXC for $21,265 on Oct 30 ’25. The EVP, Global Ops & Delivery now owns 35,630 shares after completing the transaction at $42.53 per share. On Oct 30 ’25, another insider, CORMAC TWOMEY, who serves as the Officer of the company, bought 500 shares for $42.53 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 2509597440 and an Enterprise Value of 7905847296. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.52, and their Forward P/E ratio for the next fiscal year is 3.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 0.58. Its current Enterprise Value per Revenue stands at 0.813 whereas that against EBITDA is 5.734.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.55, which has changed by -0.026563644 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $66.00, while it has fallen to a 52-week low of $36.28. The 50-Day Moving Average of the stock is -18.64%, while the 200-Day Moving Average is calculated to be -20.97%.
Shares Statistics:
It appears that CNXC traded 782.78K shares on average per day over the past three months and 642880 shares per day over the past ten days. A total of 62.21M shares are outstanding, with a floating share count of 43.50M. Insiders hold about 30.13% of the company’s shares, while institutions hold 84.84% stake in the company. Shares short for CNXC as of 1760486400 were 8635307 with a Short Ratio of 11.03, compared to 1757894400 on 7659073. Therefore, it implies a Short% of Shares Outstanding of 8635307 and a Short% of Float of 16.73.
Earnings Estimates
The performance of Concentrix Corp (CNXC) in the stock market is under the watchful eye of 4.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $2.9, with high estimates of $3.01 and low estimates of $2.75.
Analysts are recommending an EPS of between $12.2 and $11.12 for the fiscal current year, implying an average EPS of $11.37. EPS for the following year is $12.33, with 5.0 analysts recommending between $13.04 and $11.93.
Revenue Estimates
In . The current quarter, 4 analysts expect revenue to total $2.54B. It ranges from a high estimate of $2.55B to a low estimate of $2.53B. As of . The current estimate, Concentrix Corp’s year-ago sales were $2.45BFor the next quarter, 4 analysts are estimating revenue of $2.49B. There is a high estimate of $2.53B for the next quarter, whereas the lowest estimate is $2.46B.
A total of 5 analysts have provided revenue estimates for CNXC’s current fiscal year. The highest revenue estimate was $9.82B, while the lowest revenue estimate was $9.79B, resulting in an average revenue estimate of $9.81B. In the same quarter a year ago, actual revenue was $9.62BBased on 5 analysts’ estimates, the company’s revenue will be $10.13B in the next fiscal year. The high estimate is $10.28B and the low estimate is $10.02B.
